148 related articles for article (PubMed ID: 33667901)
1. Novel bisubstrate uridine-peptide analogues bearing a pyrophosphate bioisostere as inhibitors of human O-GlcNAc transferase.
Ryan P; Shi Y; von Itzstein M; Rudrawar S
Bioorg Chem; 2021 May; 110():104738. PubMed ID: 33667901
[TBL] [Abstract][Full Text] [Related]
2. Bisubstrate Ether-Linked Uridine-Peptide Conjugates as O-GlcNAc Transferase Inhibitors.
Makwana V; Ryan P; Malde AK; Anoopkumar-Dukie S; Rudrawar S
ChemMedChem; 2021 Feb; 16(3):477-483. PubMed ID: 32991074
[TBL] [Abstract][Full Text] [Related]
3. Thio-Linked UDP-Peptide Conjugates as O-GlcNAc Transferase Inhibitors.
Rafie K; Gorelik A; Trapannone R; Borodkin VS; van Aalten DMF
Bioconjug Chem; 2018 Jun; 29(6):1834-1840. PubMed ID: 29723473
[TBL] [Abstract][Full Text] [Related]
4. O-GlcNAc transferase inhibitors: current tools and future challenges.
Trapannone R; Rafie K; van Aalten DM
Biochem Soc Trans; 2016 Feb; 44(1):88-93. PubMed ID: 26862193
[TBL] [Abstract][Full Text] [Related]
5. Bisubstrate UDP-peptide conjugates as human O-GlcNAc transferase inhibitors.
Borodkin VS; Schimpl M; Gundogdu M; Rafie K; Dorfmueller HC; Robinson DA; van Aalten DM
Biochem J; 2014 Feb; 457(3):497-502. PubMed ID: 24256146
[TBL] [Abstract][Full Text] [Related]
6. O-GlcNAc Transferase: Structural Characteristics, Catalytic Mechanism and Small-Molecule Inhibitors.
Ju Kim E
Chembiochem; 2020 Nov; 21(21):3026-3035. PubMed ID: 32406185
[TBL] [Abstract][Full Text] [Related]
7. New ELISA-based method for the detection of O-GlcNAc transferase activity in vitro.
Qi J; Wang R; Zeng Y; Yu W; Gu Y
Prep Biochem Biotechnol; 2017 Aug; 47(7):699-702. PubMed ID: 28296566
[TBL] [Abstract][Full Text] [Related]
8. Feedback Regulation of
Lin CH; Liao CC; Chen MY; Chou TY
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801653
[TBL] [Abstract][Full Text] [Related]
9. Substrate and product analogues as human O-GlcNAc transferase inhibitors.
Dorfmueller HC; Borodkin VS; Blair DE; Pathak S; Navratilova I; van Aalten DM
Amino Acids; 2011 Mar; 40(3):781-92. PubMed ID: 20640461
[TBL] [Abstract][Full Text] [Related]
10. Enhanced transfer of a photocross-linking N-acetylglucosamine (GlcNAc) analog by an O-GlcNAc transferase mutant with converted substrate specificity.
Rodriguez AC; Yu SH; Li B; Zegzouti H; Kohler JJ
J Biol Chem; 2015 Sep; 290(37):22638-48. PubMed ID: 26240142
[TBL] [Abstract][Full Text] [Related]
11. Discovery of O-GlcNAc transferase inhibitors.
Gross BJ; Kraybill BC; Walker S
J Am Chem Soc; 2005 Oct; 127(42):14588-9. PubMed ID: 16231908
[TBL] [Abstract][Full Text] [Related]
12. O-GlcNAc transferase invokes nucleotide sugar pyrophosphate participation in catalysis.
Schimpl M; Zheng X; Borodkin VS; Blair DE; Ferenbach AT; Schüttelkopf AW; Navratilova I; Aristotelous T; Albarbarawi O; Robinson DA; Macnaughtan MA; van Aalten DM
Nat Chem Biol; 2012 Dec; 8(12):969-74. PubMed ID: 23103942
[TBL] [Abstract][Full Text] [Related]
13. Biological evaluation and molecular modeling of peptidomimetic compounds as inhibitors for O-GlcNAc transferase (OGT).
Albuquerque SO; Barros TG; Dias LRS; Lima CHDS; Azevedo PHRA; Flores-Junior LAP; Dos Santos EG; Loponte HF; Pinheiro S; Dias WB; Muri EMF; Todeschini AR
Eur J Pharm Sci; 2020 Nov; 154():105510. PubMed ID: 32801002
[TBL] [Abstract][Full Text] [Related]
14. Versatile O-GlcNAc transferase assay for high-throughput identification of enzyme variants, substrates, and inhibitors.
Kim EJ; Abramowitz LK; Bond MR; Love DC; Kang DW; Leucke HF; Kang DW; Ahn JS; Hanover JA
Bioconjug Chem; 2014 Jun; 25(6):1025-30. PubMed ID: 24866374
[TBL] [Abstract][Full Text] [Related]
15. Mutations in
Willems AP; Gundogdu M; Kempers MJE; Giltay JC; Pfundt R; Elferink M; Loza BF; Fuijkschot J; Ferenbach AT; van Gassen KLI; van Aalten DMF; Lefeber DJ
J Biol Chem; 2017 Jul; 292(30):12621-12631. PubMed ID: 28584052
[No Abstract] [Full Text] [Related]
16. Yeast cells as an assay system for in vivo O-GlcNAc modification.
Nakanishi H; Li F; Han B; Arai S; Gao XD
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1159-1167. PubMed ID: 28263870
[TBL] [Abstract][Full Text] [Related]
17. Nucleocytoplasmic human O-GlcNAc transferase is sufficient for O-GlcNAcylation of mitochondrial proteins.
Trapannone R; Mariappa D; Ferenbach AT; van Aalten DM
Biochem J; 2016 Jun; 473(12):1693-702. PubMed ID: 27048592
[TBL] [Abstract][Full Text] [Related]
18. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Inhibitors of O-GlcNAc Transferase That Act In Vivo Implicate Decreased O-GlcNAc Levels in Leptin-Mediated Nutrient Sensing.
Liu TW; Zandberg WF; Gloster TM; Deng L; Murray KD; Shan X; Vocadlo DJ
Angew Chem Int Ed Engl; 2018 Jun; 57(26):7644-7648. PubMed ID: 29756380
[TBL] [Abstract][Full Text] [Related]
20. A small molecule that inhibits OGT activity in cells.
Ortiz-Meoz RF; Jiang J; Lazarus MB; Orman M; Janetzko J; Fan C; Duveau DY; Tan ZW; Thomas CJ; Walker S
ACS Chem Biol; 2015 Jun; 10(6):1392-7. PubMed ID: 25751766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
